Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02013336
Title Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors South Plains Oncology Consortium
Indications

Ewing sarcoma

neuroblastoma

rhabdomyosarcoma

osteosarcoma

Therapies

Cyclophosphamide + MM-398

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.